BINDO, FRANCESCO
BINDO, FRANCESCO
Universita' degli Studi di MILANO
Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients
2023 F. Galli, F. Bindo, A. Motos, L. Fernández-Barat, E. Barbeta, A. Gabarrús, A. Ceccato, J.F. Bermejo-Martin, R. Ferrer, J. Riera, O. Peñuelas, J.Á. Lorente, D. de Gonzalo-Calvo, R. Menéndez, J. Gonzalez, S. Misuraca, A. Palomeque, R. Amaya-Villar, J.M. Añón, A. Balan Mariño, C. Barberà, J. Barberán, A. Blandino Ortiz, E. Bustamante-Munguira, J. Caballero, M.L. Cantón-Bulnes, C. Carbajales Pérez, N. Carbonell, M. Catalán-González, R. de Frutos, N. Franco, C. Galbán, A. Lopez Lago, V.D. Gumucio-Sanguino, M.D.C. de la Torre, E. Díaz, Á. Estella, E. Gallego Curto, J.L. García-Garmendia, J.M. Gómez, A. Huerta, R.N. Jorge García, A. Loza-Vázquez, J. Marin-Corral, M.C. Martin Delgado, A. Martínez de la Gándara, I. Martínez Varela, J. Lopez Messa, G. M Albaiceta, M.T. Nieto, M.A. Novo, Y. Peñasco, F. Pérez-García, J.C. Pozo-Laderas, P. Ricart, V. Sagredo, A. Sánchez-Miralles, S. Sancho Chinesta, F. Roche-Campo, L. Socias, J. Solé-Violan, F. Suarez-Sipmann, L. Tamayo Lomas, J. Trenado, A. Úbeda, L.J. Valdivia, P. Vidal, M.V. Boado, A. Rodríguez, M. Antonelli, F. Blasi, F. Barbé, A. Torres
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia
2023 F. Amati, F. Bindo, A. Stainer, A. Gramegna, M. Mantero, M. Nigro, L. Bussini, M. Bartoletti, F.B.A. Blasi, S. Aliberti
Respiratory failure in COVID-19: a patient's perspective and clinical cases
2021 F. Amati, A. Vigni, S. Misuraca, F. Bindo, A. Gramegna, A. Voza, F. Blasi, S. Aliberti
Elexacaftor-tezacaftor-ivacaftor: The new paradigm to treat people with cystic fibrosis with at least one p.Phe508del mutation
2021 A. Gramegna, M. Contarini, F. Bindo, S. Aliberti, F. Blasi
T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis
2021 M. Oriano, A. Gramegna, F. Amati, A. D’Adda, M. Gaffuri, M. Contoli, F. Bindo, E. Simonetta, C. Di Francesco, M. Santambrogio, G. Sotgiu, F. Blasi, S. Aliberti
| Titolo | Data di pubblicazione | Autori | Tipo | File | Abstract |
|---|---|---|---|---|---|
| Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients | 2023 | Bindo, FrancescoMisuraca, SofiaBlasi, Francesco + | Article (author) | - | |
| Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia | 2023 | Francesco BindoAndrea GramegnaMarco ManteroFrancesco Blasi + | Article (author) | - | |
| Respiratory failure in COVID-19: a patient's perspective and clinical cases | 2021 | Misuraca, SofiaBindo, FrancescoGramegna, AndreaBlasi, Francesco + | Book Part (author) | - | |
| Elexacaftor-tezacaftor-ivacaftor: The new paradigm to treat people with cystic fibrosis with at least one p.Phe508del mutation | 2021 | Gramegna, AndreaBindo, FrancescoAliberti, StefanoBlasi, Francesco + | Article (author) | - | |
| T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis | 2021 | M. OrianoA. GramegnaM. GaffuriF. BindoE. SimonettaF. BlasiS. Aliberti + | Article (author) | - |